Top News

DNAtrix Merges With VectorLogics

Houston-based biotechnology firm DNAtrix said today that it has merged with VectorLogics, a firm developing products for the treatment of ovarian cancer. Financial details of the merger were not announced by the companies. DNAtrix is developing adenovirus-based oncolytic virus products for treating brain cancer. The firm's lead candidate is in clinical testing at the University of Texas M.D. Anderson Cancer Center.


 

Marketplace


blog comments powered by Disqus
 

 

 

Latest Headlines

Browse Issues